The Report Arrhythmia Monitoring Devices Market Size, Share &
Trends Analysis Report By Type (ECG, Implantable, Holter, Mobile Cardiac
Telemetry), By Application, By End Use, And Segment Forecasts, 2018 – 2025
The global arrhythmia monitoring devices
market size is expected to reach USD 8.41 billion in 2025 with a CAGR of
6.8% during the forecast period, according to a new report by Grand View
Research, Inc. Continuous R&D activities in the field of cardiac monitoring
are leading to technological expansion. This, in turn, is positively
influencing the growth of the arrhythmia monitoring devices market. Wearable
diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic
arrhythmia monitoring, which is superior in comparison to conventional Holter
monitors.
Big pharma and medical
device companies are heavily investing in R&D to perform a detailed mapping
of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for
the first non-invasive cardiac mapping system, CardioInsight. It includes
wearable 252-electrode sensor vest that creates 3D electroanatomic maps of
heart by combining data from a cardiac computed tomography scan with ECG
signals collected from the chest region.
In addition to these
technologies, emergence and advancements in mobile cardiac telemetry are
leading to further progress of the overall market. In October 2017, Abbott
received FDA clearance for Confirm Rx, a smartphone-compatible implantable
cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced
its FDA approval for Resonate, a line of cardiac resynchronization therapy
defibrillator and cardioverter defibrillator systems for the cardiac
management.
Access
Research Report of Arrhythmia Monitoring Devices Market @ https://www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market
Further key findings from the report suggest:
· The arrhythmia monitoring devices market is
highly competitive and is rapidly evolving with numerous potential market
players
· Holter monitors dominated the market in
terms of revenue in 2017. On the other hand, mobile cardiac telemetry is
expected to witness the fastest growth rate during the forecast period
· Atrial fibrillation dominated the market in
terms of revenue in 2017. The growth in the number of untreated cases of
arrhythmias are leading to increasing need for advanced cardiac monitoring
devices
· Heightened adoption of sophisticated
technologies has led to the expansion of the market. Kardia Mobile by AliveCor
captures ECG in 30 seconds projecting the heart rhythm for conditions such as
atrial fibrillation
· The hospitals and clinics segment held the
largest share in the market in 2017. On the other hand, diagnostic centers are
likely to experience the fastest growth over the forecast period
· North America commanded the leading share
in the market in 2017 due to faster regulatory approvals for innovative devices
and procedures
· AliveCor, Inc.; Applied Cardiac Systems;
BioTelemetry, Inc.; BIOTRONIK; Fukuda Denshi Co., Ltd.; GE Healthcare; iRhythm;
Medi-Lynx; St. Jude Medical (Abbott); Medtronic; Nihon Kohden Corporation;
Nuubo; and Spacelabs Healthcare are some of the key players operating in this
market.
Grand View Research has
segmented the global arrhythmia monitoring devices market based on type,
application, end use, and region:
Arrhythmia Monitoring Devices Type Outlook (Revenue, USD
Million, 2014 - 2025)
·
ECG Monitors
·
Implantable Monitors
·
Holter Monitors
·
Mobile Cardiac Telemetry
Arrhythmia Monitoring Devices Application Outlook (Revenue,
USD Million, 2014 - 2025)
·
Bradycardia
·
Tachycardia
·
Atrial Fibrillation
·
Ventricular Fibrillation
·
Premature Contraction
·
Others
Arrhythmia Monitoring Devices End Use Outlook (Revenue,
USD Million, 2014 - 2025)
·
Hospitals & Clinics
·
Diagnostic Centers
·
Others
Arrhythmia Monitoring Devices Regional Outlook (Revenue,
USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
